Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Dooley, Kelly E ^a   Lahlou, Ouafae ^b   Ghali, Iraqi ^c   Knudsen, Janine ^d   Elmessaoudi, My Driss ^e   Cherkaoui, Imad ^b   El Aouad, Rajae ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUT NATIONAL D HYGIÈNE   (Morocco)

^c IBN SINA HOSPITAL   (Morocco)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e Institut Pasteur du Maroc   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; MOROCCO; OUTCOME ASSESSMENT; RETREATMENT; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT FAILURE; TUBERCULOSIS;

ADULT; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOROCCO; OUTCOME ASSESSMENT (HEALTH CARE); RETREATMENT; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; TUBERCULOSIS; YOUNG ADULT;

EID: 79952050322     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-140     Document Type: Article

References (24)

1. World Health Organization, Global tuberculosis control - epidemiology, strategy, financing. WHO Report 2009, WHO/HTM/TB/2009.411 http://www.who.int/tb/ publications/global-report/2009/en/index.html
2. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. MC Becerra J Freeman J Bayona SS Shin JY Kim JJ Furin B Werner A Sloutsky R Timperi ME Wilson M Pagano PE Farmer, Int J Tuberc Lung Dis 2000 4 2 108 114 10694087 (Pubitemid 30123642)
3. Antituberculosis drug resistance among retreatment tuberculosis patients in a referral center in Taipei. CY Chiang CJ Hsu RM Huang TP Lin KT Luh, J Formos Med Assoc 2004 103 6 411 415 15278183
4. World Health Organization, Treatment of tuberculosis. Guidelines for national programmes. WHO/CDS/TB/2003.313. Geneva, Switzerland 3 2003
5. Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003. SE Ottmani M Zignol N Bencheikh L Laasri N Chaouki J Mahjour, Int J Tuberc Lung Dis 2006 10 12 1367 1372 17167954 (Pubitemid 44924591)
6. World Health Organization, Anti-tuberculosis resistance in the world: WHO/IUATLD global project on anti-tuberculosis drug surveillance 2002-2007, Report number 4 2008
7. Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens. A Mak A Thomas M Del Granado R Zaleskis N Mouzafarova D Menzies, Am J Respir Crit Care Med 2008 178 3 306 312 10.1164/rccm.200802-240OC 18511706
8. Management of pulmonary tuberculosis patients in an urban setting in Zambia: a patient's perspective. C Mulenga D Mwakazanga K Vereecken S Khondowe N Kapata IC Shamputa H Meulemans L Rigouts, BMC Public Health 2010 10 756 10.1186/1471-2458-10-756 21138565
9. Patients with previously treated tuberculosis no longer neglected. M Zignol A Wright E Jaramillo P Nunn MC Raviglione, Clin Infect Dis 2007 44 1 61 64 10.1086/509328 17143816 (Pubitemid 44968985)
10. Time to abandon the standard retreatment regimen with first-line drugs for failures of standard treatment. MA Espinal, Int J Tuberc Lung Dis 2003 7 7 607 608 12870678 (Pubitemid 36806852)
11. Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? HT Quy NT Lan MW Borgdorff J Grosset PD Linh LB Tung D van Soolingen M Raviglione NV Co J Broekmans, Int J Tuberc Lung Dis 2003 7 7 631 636 12870683 (Pubitemid 36806857)
12. Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. B Temple I Ayakaka S Ogwang H Nabanjja S Kayes S Nakubulwa W Worodria J Levin M Joloba A Okwera KD Eisenach R McNerney AM Elliott PG Smith RD Mugerwa JJ Ellner EC Jones-Lopez, Clin Infect Dis 2008 47 9 1126 1134 10.1086/592252 18808360
13. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. W Lew M Pai O Oxlade D Martin D Menzies, Ann Intern Med 2008 149 2 123 134 18626051 (Pubitemid 352008599)
14. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. A Thomas PG Gopi T Santha, Int J Tuberc Lung Dis 2005 9 556 561 15875929 (Pubitemid 40646843)
15. Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients. F Pulido JM Pena R Rubio, Arch Intern Med 1997 157 227 232 10.1001/archinte.157.2.227 9009982 (Pubitemid 27058159)
16. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. R Panjabi GW Comstock JE Golub, Int J Tuberc Lung Dis 2007 11 8 828 837 17705947 (Pubitemid 47227613)
17. Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. TM Comolet R Rakotomalala H Rajaonarioa, Int J Tuberc Lung Dis 1998 2 11 891 897 9848609 (Pubitemid 28539471)
18. Adherence is associated with the quality of professional-patient interaction in Directly Observed Treatment Short-course, DOTS. P Mishra EH Hansen S Sabroe KK Kafle, Patient Educ Couns 2006 63 1-2 29 37 10.1016/j.pec.2005.08.006 16242297 (Pubitemid 44348862)
19. Default from tuberculosis treatment in Tashkent, Uzbekistan; who are these defaulters and why do they default? E Hasker M Khodjikhanov S Usarova U Asamidinov U Yuldashova MJ van der Werf G Uzakova J Veen, BMC Infect Dis 2008 8 97 10.1186/1471-2334-8-97 18647400
20. Current status of treatment completion and fatality among tuberculosis patients in Spain. JA Cayla JA Caminero R Rey N Lara X Valles H Galdos-Tanguis Working Group on Completion of Tuberculosis Treatment in Spain, Int J Tuberc Lung Dis 2004 8 4 458 464 15141739 (Pubitemid 38624855)
21. Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001. TH Holtz J Lancaster KF Laserson CD Wells L Thorpe K Weyer, Int J Tuberc Lung Dis 2006 10 6 649 655 16776452 (Pubitemid 43845026)
22. Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment. J Volmink P Garner, BMJ 1997 315 7120 1403 1406 9418086 (Pubitemid 27510721)
23. Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. S Thiam AM LeFevre F Hane A Ndiaye F Ba KL Fielding M Ndir C Lienhardt, JAMA 2007 297 4 380 386 10.1001/jama.297.4.380 17244834 (Pubitemid 46155799)
24. Website of the Ministry of Health of Morocco. http://srvweb.sante.gov.ma/ Programmes/Pages/default.aspx